Skip to main content
. 2020 Sep 14;11(2):389–406. doi: 10.1016/j.jcmgh.2020.09.004

Table 1.

Clinical and Biochemical Characteristics of Subjects With Gene Expression Data (N = 144) Shown in Figure 1

Characteristics Non-NASH (n = 87) NASH (n = 57) P value
Age (y) 37.0 (30.0–46.0) 39.0 (34.0–47.0) .472
Sex (male %) 13 (14.9) 12 (21.1) .344
BMI (kg/m2) 41.0 (37.9–45.9) 43.7 (38.9–48.8) .319
Fasting glucose (mg/dL) 89.0 (80.0–99.0) 94.0 (86.0–100.0) .172
Fasting insulin (μU/L) 9.6 (6.1–12.7) 14.5 (11.3–18.5) 2.2E-04
HOMA-IR 2.1 (1.5–3.1) 3.3 (2.5–4.2) .001
Triglycerides (mg/dL) 120.8 (89.5–153.0) 161.5 (110.0–219.0) 2.7E-04
Total cholesterol (mg/dL) 168.5 (147.5–194.8) 172.0 (148.0–204.8) .799
HDL-C (mg/dL) 36.0 (32.0–44.0) 34.5 (31.0–41.0) .140
AST (IU/mL) 26.0 (20.3–31.0) 29.5 (25.0–36.3) .016
ALT (IU/mL) 26.0 (18.0–35.0) 28.5 (23.0–41.8) .024
GGT (IU/mL) 16.5 (13.0–24.8) 23.0 (18.0–32.8) 2.4E-04

NOTE. Data are shown as median (interquartile range) or n (%) according to distribution of variables. Data were analyzed using Mann-Whitney U or χ2 test. P values in bold indicate significant differences.

ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment for insulin resistance.